Heraeus Noblelight is a leader in the production of specialty light sources and systems. The globally active Fusion US business group is a specialist in microwave based UV curing applications.
"We believe the activities of the two companies complement each other superbly. The new combined technology portfolio covers distinct methods for producing UV light, enabling us to now offer new areas of application," says Rainer Küchler, managing director of Heraeus Noblelight.
While Heraeus Noblelight has focused on the printing industry and on the UV disinfection of packaging materials, drinking water, and industrial water, Fusion UV has applied UV technology in the production of optical fibers and screens for smartphones and other applications. The companies have also focused on different regions, so the combination now yields broad market coverage with direct access to all key industrial markets in the United States, Europe and Asia.
With headquarters in Hanau, Germany, and subsidiaries in the United States, the United Kingdom, France, China, and Australia, Heraeus Noblelight GmbH is a global market and technology leader in the production of specialty light sources. Heraeus Noblelight achieved annual revenues of E103 million in 2011 and has 731 employees around the world. The company develops, manufactures, and markets infrared heaters and ultraviolet lamps for applications in industrial production technology, environmental protection, medicine and cosmetics, research, and analytic measurement technology.
Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company with over 160 years of tradition. Our fields of competence include precious metals, materials and technologies; sensors; biomaterials and medical products, as well as dental products, quartz glass, and specialty light sources. With product revenues of E4.8 billion and precious metal trading revenues of E21.3 billion, as well as more than 13,300 employees in more than 120 subsidiaries worldwide, Heraeus holds a leading position in its global markets.For additional information, please contact:
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
24.01.2017 | Physics and Astronomy
24.01.2017 | Life Sciences
24.01.2017 | Health and Medicine